Algen, a venture-backed preclinical stage biotech company, is using CRISPR to uncover disease-driving RNA messages to find treatments for cancer and diseases with high unmet needs. Originated from UC Berkeley, Algen is the first to elegantly fuse high throughput, wide-scale gene editing and state-of-the-art machine learning to find first-in-class drugs that modulate RNA messages at single-cell resolution. Algen’s research group focuses on developing and applying novel functional genomics technologies to address scientific challenges in drug discovery and deliver innovative, patient-centric medicines for the toughest-to-treat diseases.

AcuraStem is a near-to-clinic, patient-based, biotechnology company pioneering how treatments are developed for neurodegenerative diseases — including sporadic ALS and FTD — using our proprietary, best-in-class, disease-modeling platform, iNeuroRx®, the gold standard for discovering novel, effective and broadly-acting treatments.

BioLegend develops world-class, cutting-edge antibodies and reagents for biomedical research, manufactured in our state-of-the-art facility in San Diego, CA. Our mission is to accelerate research and discovery by providing the highest quality products at an outstanding value and with superior customer and technical support.

「Chain Reaction Ltd.」前銳科技 簡介：
於2019年以70億美元把共同創辦的公司Mellanox賣給輝達(Nvidia)後不到一年，以色列創業家Alon Webman整合了一個全新的團隊重新成立了Chain Reaction。本公司為研發區塊鏈(Blockchain)系統硬體電路設計並整合加密技術(Cryptography)平台之新創公司。鎖定在未來區塊鏈爆發性成長趨勢中所謂「處處都需要加密(Cryptography everywhere)」的硬體需求。
本公司產品核心理念為提供高加速運算效能之硬體系統並結合優化區塊鏈零知識證明(Zero-Knowledge Proofs) 之加密演算法，以解決目前於雲端伺服器上區塊鏈計算之加速效能、隱私安全與規模化之三角難題。本公司產品為未來區塊鏈多元應用或元宇宙同態加密(Homomorphic Encryption)高運算需求應用舖路，主要研發產品為應用於雲端伺服器上之加密演算處理器(3PU, Privacy Preserving Process Unit)；另外目前已開發完成第一代比特幣Crypto Mining ASIC產品，並於2022年開始量產製造銷售。
本公司研發總部設置於以色列，並分別在台灣新竹科學園區與美國矽谷設置分公司以招募半導體及加密技術研發人才，提供整合區塊鏈加密演算與IC設計並結合台灣半導體產業鏈的創新解決方案。
Chain Reaction Ltd. 曾獲Intel選入2020年以色列十大新創扶植公司，並為唯一硬體公司。

Chain Reaction is engineering the future of disruptive blockchain and privacy technologies. Our products accelerate compute performance with low-power, high-speed hardware, enabling companies to adopt and scale solutions to the world’s most complex problems. We partner with cloud, data centers, and enterprise to transform compute infrastructure. The first product line targets enterprise data centers with custom ASICs and hashing systems that optimize for low-power, high-performance bitcoin mining. The second product line targets cloud service providers and legacy data centers with our 3PU™ that dramatically accelerates real-time operations of Privacy Enhancing Technologies on encrypted data. The 3PU™ transforms the cloud into a trusted environment, enabling verticals that rely on confidential big data to use the cloud (such as financial institutions, healthcare & big pharma, defense & government, and oil & gas). Our purpose-built, high-performance products power the next generation of secure, scalable, green computing, to help protect people, privacy, and the planet.

We are a Specialty CRO (Contract Research Organization) that helps clients accelerate their drug development by providing innovative and best in class bioassays.
Our leaders are especially passionate about mentoring and fostering a stronger and brighter Bioscience community from Taiwan, in fact, 3 previous Presidents of Chinese Bioscience Association are members of the company.

Founded in 1919 through the merger of eight Japanese celluloid companies, our company has achieved a unique development. We are expanding our business globally in various fields beyond the boundaries of chemistry, such as precision pyrotechnic systems.

Eos BioInnovation is an operating company based in the Boston, Massachusetts area dedicated to incubating, launching, investing in, and building early-stage companies emerging from leading academic labs and research institutions in the regenerative medicine (RM) field.  Based on our unique relationship with Harvard (our CEO Brock Reeve was the Executive Director of the Harvard Stem Cell Institute (HSCI) for over 16 years), our initial and primary focus will be working on projects and investing in startups from HSCI, the 8 Harvard affiliated hospitals (e.g., Mass General, Boston Children's, Mass Eye & Ear, Brigham Women's, Dana Farber) and the overall Harvard ecosystem (e.g., The Wyss Institute for Biologically Inspired Engineering).  We also have close ties and working relationships with key faculty members and researchers at MIT, Stanford, UCSF, UC Berkeley, the Mayo Clinic, California Institute for Regenerative Medicine, etc.  An Executive Summary of Eos describing the company, its uniqueness and its vision can be separately provided via email.  

Founded in 1997 as a California Corporation, Global Communication Semiconductors, LLC ("GCS") is an ISO-certified premier III-V compound semiconductor (GaAs, InP and GaN ) wafer fabrication foundry service provider that manufactures technology leading, high performance semiconductor devices. Portfolio offerings include Radio Frequency Integrated Circuits (RFIC) and millimeter wave integrated circuits for wireless markets, power devices for power electronics, and Photodetectors, lasers and photonic IC (PIC) for optical communication, biomedical, industrial and consumer electronics markets.

Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.

InoBat Auto specialises in the pioneering research, development, manufacture, and provision of premium innovative electric batteries custom-designed to meet the specific requirements of global mainstream and specialist OEMs within the automotive, commercial vehicle, motorsport, and aerospace sectors. A European based battery manufacturer, InoBat already has a battery research and development facility and pilot line under development in Slovakia. InoBat is backed by a strong consortium of investors and technology companies,  including strategic investors and partners such as Rio Tinto, CEZ, Ideonomics, Amara Raja, IPM, Matador, AEN, MSM Group. InoBat has also approved for grant financing under the EU sponsored programme, Important Projects for Common European Interest, and already received a grant from the Slovak Government.
 

Battery Academy is an educational campaign powered by InoBat, which aims to increase awareness of the battery ecosystem among students, graduates, young professionals, battery enthusiasts and others. 
 https://thebatteryacademy.com/

Instant NanoBiosensors (INB) is an innovative life sciences company that has developed next generation, cost-effective ultra-sensitive real-time immunoassay platforms that advance precision health for life sciences research and diagnostics. Our platform , Light Sensing Biomarker Analyzer, based on patented FOPPR (Fiber Optic Particle Plasmon Resonance) and IN-Chip (auto-flowing microfluidic chip) technologies with 35+ global patents ( US, UK, Europe, China, Japan and Taiwan) for the life science research and in vitro diagnostics markets enables customers to reliably detect protein biomarkers in extremely low concentrations (5 orders) in blood, serum and other fluids that, in many cases, are undetectable using conventional, analog immunoassay technologies, and also allows researchers to define and validate the function of novel protein biomarkers that are only present in very low concentrations and have been discovered using technologies such as mass spectrometry or other capital instrument . The business opportunity includes co-development, method technology transfer, technology licensing, and IVD applications. We hope to build more strategic partnership with international associates to achieve the mission of FOPPR inside.

We are executing a multinational innovation program, called as “UREKA GlobalStars Taiwan digital industrial collaborations”, in partnership with Centre for Process Innovation (CPI), a British technology and innovation social enterprise, for the purpose of enabling UK industrial digital companies to access, collaborate with and find new markets in Taiwan. Meanwhile, we are in collaboration with global research institutes including Stanford medical center, Brigham and Women's Hospital, Amsterdam UMC, New Castle and University College London in healthcare field. This can help us to provide the information of third-party verification of our technology to pharmaceutical companies so that we can accumulate our capability abundantly for future out-licensing transaction. 

Workshop of Photonics (WOP) journey started in 2003 when extensive research in the field of femtosecond (fs) laser micromachining has begun. Since the beginning, we are continually investing in research, striving to always be in front of micron-scale challenges, while our past experience is based on long time research and previous theoretical and practical experience of the team members, that are incorporated in the outcomes of the proposal. Several research articles and patents are the proof that the team is allocated considerable resources for the development of the solution and also is the proof that they are aware of the major scientific and technology trends – actually the team is a shaper of those trends. We deliver full-service solution: - Rapid prototyping services; - Manufacturing services; - Laser workstations development. Shortly about us and our motivation to participate: - High Tech company specializing in Ultrashort Pulse Laser Technologies for industrial manufacturing; - Application laboratory, solution provider for Semicon, Biotech, Automotive, Medtech, etc. industries; - Precision engineering solutions, based on laser micro-processing; - Materials: glass/sapphire/silicon wafer processing, metal foils, Fiber Bragg grating inscription, etc. - Lately, Workshop of Photonics is actively promoting company offerings in Taiwan market. Multiple connections among integrators and end users as well as with trade companies. Thus Workshop of Photonics is enthusiastic about X-Talent program which can bring closer our countries and businesses

Based in San Diego, Kneron Inc. is a start-up dedicated to local/edging AI solutions. Kneron was the winner of Tengfei Award by Tencent and won the third place in Innovation Competition of International Talents, Silicon Valley Division.

At KII, here in San Diego, CA, we are a semiconductor packaging company.  We have in-house ceramic packaging (in San Diego, CA) and IC-Substrate manufacturing from our parent company in Japan.  Here we also assembly customer's semiconductor devices with wire-bond and flip-chip technologies.

Mucker Capital started about 10 years ago and has grown from an accelerator to cover everything from pre-seed to series A investments, including Honey (acquired by PayPal for $4B), ServiceTitan (last valued at $9.5B), and Emailage (acquired by LexisNexis parent RELX for $500M). As one of the top early-stage venture Capital firms in the US, Mucker's portfolio companies have raised a total $8 billion in additional outside funding.

We research power electronics simulation technology and support manufacturers' development with simulation technology, from circuit analysis to hardware development and education business by utilizing SPICE/MATLAB Simulink.Last year we started with a capital of 3700US$ and sold 12500US$. We aim to expand our business both domestically and internationally and are looking for researchers for technology development.

ANEUVO® is a Platform and Therapy Development company focused on treating chronic injuries and conditions that have not been curable through traditional pharmaceutical approaches.

Onyx Healthcare USA is a subsidiary of the ASUS Computer Group that has been providing innovative and medically certified (CE/FCC Class B, UL/EN60601, CSA) healthcare computing solutions to assist workflows in operating suites, nursing stat ions, patient wards, ambulatory care, and hospital administrations worldwide. Onyx Healthcare USA, Inc., with 15+ years of medical design experiences, leverages embedded computing technology to design and manufacture medical grade (UL60601-1) fanless all-in-one panel PC system platforms and embedded boards as the building blocks to medical device OEM and healthcare IT business.

PharmaEssentia Corporation is a rapidly growing biopharmaceutical innovator. We are leveraging deep expertise and proven scientific principles to deliver effective new biologics for challenging diseases in the areas of hematology and oncology, with one approved product and a diversifying pipeline. We believe in the potential to improve both health and quality of life for patients with limited options today through the combination of rigorous research and innovative thinking.
Founded in 2003 by a team of Taiwanese-American executives and renowned scientists from U.S. biotechnology and pharmaceutical companies, today we are listed on the Taipei Exchange (TPEx: 6446) and are expanding our global presence with operations in the U.S., Japan, China and Korea, along with a world-class biologics production facility in Taichung, Taiwan.
In order to continue our mission to create better medicines, PharmaEssential plans to launch a US R & D center, named PharmaEssentia Innovation Research Center (PIRC) in 2023. PIRC laboratory and office space is currently under construction. The scheduled completion date is in June/July, 2023.
 

Taiwania Capital is a venture capital firm founded in August 2017 by the National Development Fund of the Executive Yuan of Taiwan and private enterprises. Our mission is to establish a partnership with companies worldwide and boost Taiwan’s economic growth.

We focus on investing in early-stage companies and have managed six funds till 2022.

We focus on financial returns, but more than that, by linking technology and capital, we aspire to create a robust ecosystem in Taiwan that is rooted in entrepreneurial innovation. 

Taiwania Capital is named after Taiwania cryptomerioides, a unique tree species that took its name from Taiwan in 1906. With heights reaching up to 90 meters, the Taiwania tree is one of the tallest tree species in Asia, and surrounding it is a diverse and vibrant ecosystem. By linking technology and capital, Taiwania Capital aspires to also create a robust ecosystem in Taiwan that is rooted in entrepreneurial innovation.

Taboola helps people find relevant content online, matching them with news stories, articles, blogs, videos, apps, products and other content they’re likely to want to explore.
How do we know what they’ll like? Using machine-learning algorithms, our technology analyzes hundreds of signals to capture exactly what kind of content is most likely to engage each individual. We do that more than 450 billion times a month for more than one billion unique users.

Since we opened our doors in 2006, we have grown to become the leading discovery platform on the open web, serving a combination of the world’s best brands and the most respected global publishers.

Taboola is headquartered in New York City with local offices in Los Angeles, London, Tel Aviv, New Delhi, Bangkok, São Paulo, Beijing, Shanghai, Istanbul, Seoul, Sydney, Tokyo and Taiwan.

Our mission has been to keep improving the construction methods of offshore and civil projects. By continuously challenging the current construction practices, we develop tailored methods to ensure projects are executed safely, on time, and within budget. Our dedication to smart design solutions helped us grow rapidly. At the same time, we still keep our tradition of being bold, flexible, and creative.
TWD為總部在荷蘭鹿特丹的海事工程設計顧問公司，成立至今主要以海事工程為發展領域，特別專精於離岸風電安裝階段所遇到的工程問題，同時也在所有海洋工程、水下工程、岸基工程皆累積許多經驗。因為特殊彈性的商業模式定位，TWD能與大型海事工程中各種參與者合作，目前也已參與全世界70~80%離岸風場開發案，也在離岸風電施工延伸出的相關工程問題如海洋繫泊、大型裝備運送、船隻繫纜、重型吊掛等積累相當多的實例參與經驗。

Tachyum is building the world’s fastest AI supercomputer to enable data centers that are more
powerful than the human brain. Its soon-to-be-launched Prodigy Universal Processor delivers
industry-leading performance, cost and power benefits to a $50B market that is expected to grow
at 20 percent a year. Early adopter customers and partners can use Prodigy software emulation
systems today that will enable them to transition their existing applications that demand high
performance and low power to run optimally on Prodigy processors, which ship in volume later this
year, with fully functional FPGA emulation system boards also available for pre-order.

- Tachyum is developing the next generation microprocessor and artificial intelligence chip – Prodigy™
- Prodigy is characterized by better performance (>3x) and lower energy consumption (up to 10x) compared to its competition
- Tachyum is in the final stage of development, preparing for mass production in 2022 and IPO in 2024

Proven Track Record
Founders and management have previously worked for nVidia, AMD and Intel; and successfully built  and exited Skyera which was acquired by WD and SandForce acquired for over US$377m.

Unique Universal Microprocessor/HPC/AI Architecture
will unlock unprecedented performance, power efficiency, and cost advantages, to solve the most complex problems in big data analytics, deep learning, mobile, and large-scale computing.

Taisys India is positioned as M2M Service provider. We deliver M2M SIM/eSIM connectivity solution to server all use cases. Our M2M Platform offers total solutions for customers activation needs. The mission of Taisys India is to be market leader in global connectivity and AIoT solution.

Tubis Technology Inc., funded in 2013, develops mmWave semiconductor ICs, phased-array antenna and communication systems for 5G Cellular and Satellite Communications market. Currently 20 people and is expected to increased to 35 people.

Vizuro is an innovator and solution provider of Causal AI with its powerful applications in diverse sectors. We utilize our proprietary self-learning, explainable and actionable AI on a managed, data-science-as-a-service platform to quickly deploy bespoke applications in an expedited timeframe. We serve global clients in various sectors and sizes, ranging from Fortune 100 enterprises to startups.

Wistron Information Technology & Services Corporation (WITS) is a CMMI Level 5, ISO 27001 certified, multifaceted and professional IT service company that is part of Wistron Group, a Fortune Global 500 company. WITS has 30 years of experience in providing IT consulting and outsourcing services to Fortune 500 companies worldwide. 
Founded in June 1992, it is now a leading IT service provider with offices in Taipei, Hsinchu, Taichung, Tainan, Tokyo, Osaka, Beijing, Wuhan, Dalian, Shanghai, Zhuhai, Guangzhou, Shenzhen, Hong Kong, and Irvine, California supported by more than 8,600 employees worldwide.
WITS encourages diversity, thrives on each other’s strengths and is devoted to creating an inclusive environment at our offices around the world. We will invest in talent’s growth and are committed to supporting every member.

Company intro video: https://bit.ly/3e7HuAD

The ZalaZONE Industrial Park Ltd., through its ZalaZONE trainee programme, aims to contribute to the provision of labour mobility for the companies operating in the park and for the new enterprises, in co-operation with ZalaZONE Research & Technology Center and the available university research groups.  One of the aims of the programme is to create a space for cooperation between industrial and economic players and the university sector, and to promote cooperation between the partners. 
The focus is on creating an internationally high-quality education and research environment with high added value for the region's competitiveness. 
The engineers working in the various laboratories and workshops, as well as the partners coming to the park, will seek R&D and technical solutions to emerging industrial problems and challenges in areas such as:
automotive development, testing and validation, mechatronics, software and communication systems development, engineering and product design, manufacturing and materials technologies.